368
S. B. Kanawade, S. P. Patil, P. S. Nikam, S. A. Gangurde, M. N. Jachak, and R. B. Toche
Vol 49
50-(4-Chlorophenyl)-30,40-dihydro-40-oxo-10H-spiro[cyclopen
(352.98): C, 47.47; H, 2.56; N, 11.86. Found: C, 47.31; H,
2.42; N, 11.76.
tane-1,20-thieno[2,3-d]pyrimidine]-60-carboxamide (10a). This
compound was obtained as white amorphous solid, 0.353 g
(98%), mp 264–265ꢂC; IR: 3490m, 3469m, 3380m, 3290m,
5-(4-Chlorophenyl)-3,4-dihydro-2-(3-chloropropyl)-4-oxo-
thieno-[2,3-d]pyrimidine-6-carboxamide (11d). This compo-
und was obtained as colorless amorphous solid, 0.247 g
(65%), mp 274–275ꢂC; IR: 3456m, 3356m, 3311m, 3169m,
3312m, 2935s, 1660s, 1630m cmꢀ1 1H NMR (DMSO-d6): d
;
1.90–1.92 (m, 4H, 2CH2), 2.18–2.24 (m, 4H, 2CH2), 6.47
(bs, 2H, amide NH2), 7.32 (d, J ¼ 8.3 Hz, 2H, Ar-H), 7.50 (d,
J ¼ 8.3 Hz, 2H, Ar-H), 7.52 (bs, 1H, NH), 8.26 (bs, 1H, NH);
ms: m/z 361 (Mþ, 100%), 363 (Mþ2, 33%). Anal. Calcd. for
C17H16ClN3O2S (361.07): C, 56.43; H, 4.46; N, 11.61. Found:
C, 56.34; H, 4.59; N, 11.51.
1672s, 1649m cmꢀ1 1H NMR (DMSO-d6): d 2.15–2.17 (m,
;
4H, 2CH2), 3.31 (m, 2H, CH2), 6.51–7.39 (bs, 2H, amide
NH2), 7.36 (d, J ¼ 8.3 Hz, 2H, Ar-H), 7.52 (d, J ¼ 8.3 Hz,
2H, Ar-H), 11.30 (bs, 1H, NH); ms: m/z 381 (Mþ, 100%),
383 (Mþ2, 65%), 385 (Mþ4, 11%). Anal. Calcd. for
C16H13Cl2N3O2S (381.01): C, 50.27; H, 3.43; N, 10.99.
Found: C, 50.19; H, 3.19; N, 10.85.
50-(4-Chlorophenyl)-30,40-dihydro-40-oxo-10H-spiro[cyclohex-
ane-1,20-thieno[2,3-d]-pyrimidine]-60-carboxamide (10b). This
compound was obtained as white amorphous solid, 0.371 g
(99%), mp 240–242ꢂC; IR: 3498m, 3473m, 3381m, 3288m,
General procedure for the synthesis of compounds 12a–c. A
mixture of compound 2 (0.295 g, 0.001 mol) and aromatic alde-
hyde (0.001 mol) in ethanol (10 mL) with catalytic amount of
piperidine was refluxed in oil bath with stirring for 10–12 h
(TLC check, chloroform: methanol, 8:2). The reaction mixture
was cooled and stirred in crushed ice (25 mL). The residue
obtained was filtered and purified by column chromatography
(silica gel 5–20 lm) in chloroform: methanol (8:2) as an eluent.
2,5-Di-(4-chlorophenyl)-1,2,3,4-tetrahydro-4-oxothieno[2,3-d]-
pyrimidine-6-carboxamide (12a). This compound was obtained
as colorless amorphous solid, 0.242 g (52%), mp 310–312ꢂC;
3213m, 2937s, 1654s, 1629m cmꢀ1 1H NMR (DMSO-d6): d
;
1.19–1.48 (m, 4H, 2 CH2), 1.76–1.87 (m, 4H, 2 CH2), 2.25 (m,
2H, CH2), 5.37 (bs, 1H, NH), 7.18–7.38 (bs, 2H, amide NH2),
7.27 (d, J ¼ 8.3 Hz, 2H, Ar-H), 7.44 (d, J ¼ 8.3 Hz, 2H, Ar-
H), 8.30 (s, 1H, NH); 13C NMR (DMSO-d6): d 20.9, 24.4,
26.3, 36.3, 41.2, 70.3, 110.1, 117.7, 127.8, 131.0, 132.3, 134.1,
139.6, 159.1, 160.3, 163.0; ms: m/z 375 (Mþ, 100%), 377
(Mþ2, 33%). Anal. Calcd. for C18H18ClN3O2S (375.08): C,
57.52; H, 4.83; N, 11.18. Found: C, 57.46; H, 4.68; N, 11.30.
General procedure for the synthesis of compounds 11a–d. A
mixture of 2 (0.295 g, 0.001 mol) and various acid chlorides
(0.001 mol) were stirred at 115ꢂC in glacial acetic acid (4 mL)
for 10–12 h (TLC check, chloroform: methanol, 8:2). Excess
acetic acid was distilled off under vacuum, and residue
obtained was poured over crushed ice (15 mL), filtered and
dried. The solid was then purified by column chromatography
(silica gel 5–20 lm) in chloroform: methanol (8:2) as an
eluent.
IR: 3475m, 3327m, 3308m, 1689s, 1641s cmꢀ1 1H NMR
;
(DMSO-d6): d 5.82 (s, 1H, CH), 6.31–6.48 (bs, 2H, amide
NH2), 7.42 (d, J ¼ 8.1 Hz, 2H, Ar-H), 7.49 (d, J ¼ 8.1 Hz,
2H, Ar-H), 7.62 (d, J ¼ 8.4 Hz, 2H, Ar-H), 8.4 (bs, 1H, NH),
8.16 (d, J ¼ 8.4 Hz, 2H, Ar-H), 12.76 (bs, 1H, NH); ms: m/z
417 (Mþ, 100%), 419 (Mþ2, 65%), 421 (Mþ4, 11%). Anal.
Calcd. for C19H13Cl2N3O2S (417.01): C, 54.56; H, 3.13; N,
10.05. Found: C, 54.64; H, 3.24; N, 9.89.
5-(4-Chlorophenyl)-1,2,3,4-tetrahydro-2-(2,4-dimethoxy-
phenyl)-4-oxothieno[2,3-d]-pyrimidine-6-carboxamide (12b). This
compound was obtained as pale green amorphous solid, 0.243
g (55%), mp 330–332ꢂC; IR: 3472m, 3330m, 3310m, 1687s,
5-(4-Chlorophenyl)-3,4-dihydro-2-methyl-4-oxothieno[2,3-d]-
pyrimidine-6-carboxamide (11a). This compound was obtained
as an off white amorphous solid, 0.207 g (65%), mp 277–
;
280ꢂC; IR: 3490m, 3470m, 1668s, 1629m cmꢀ1 1H NMR
1641m, 1242m cmꢀ1 1H NMR (DMSO-d6): d 3.84 (s, 3H,
;
(DMSO-d6): d 2.14 (s, 3H, CH3), 6.32–6.54 (bs, 2H, amide
NH2), 7.34 (d, J ¼ 8.4 Hz, 2H, Ar-H), 7.49 (d, J ¼ 8.4 Hz,
2H, Ar-H), 11.29 (bs, 1H, NH); ms: m/z 319 (Mþ, 100%), 321
(Mþ2, 33%). Anal. Calcd. for C14H10ClN3O2S (319.02): C,
52.59; H, 3.15; N, 13.14. Found: C, 52.48; H, 3.21; N, 13.21.
5-(4-Chlorophenyl)-3,4-dihydro-2-phenyl-4-oxothieno[2,3-d]-
pyrimidine-6-carboxamide (11b). This compound was obtained
as white amorphous solid, 0.236 g (62%), mp 268–270ꢂC; IR:
OCH3), 3.86 (s, 3H, OCH3), 5.86 (s, 1H, CH), 6.52–7.11 (bs,
2H, amide NH2), 6.65–6.80 (m, 2H, Ar-H), 7.72 (d, 1H, Ar-
H), 8.21 (d, J ¼ 8.3 Hz, 2H, Ar-H), 8.32 (d, J ¼ 8.3 Hz, 2H,
Ar-H), 8.50 (bs, 1H, NH), 9.78 (bs, 1H, NH); ms: m/z 441
(Mþ, 100%), 443 (Mþ2, 33%). Anal. Calcd. for
C21H18ClN3O4S (441.06): C, 56.82; H, 4.09; N, 9.47. Found:
C, 56.95; H, 4.21; N, 9.35.
5-(4-Chlorophenyl)-1,2,3,4-tetrahydro-2-(4-nitrophenyl)-4-
oxothieno[2,3-d]pyrimidine-6-carboxamide (12c). This com-
pound was obtained as yellow amorphous solid, 0.236 g
(55%), mp 329–330ꢂC; IR: 3476m, 3339m, 3315m, 1687s,
1
3488m, 3468m, 2931s, 1665s, 1624m cmꢀ1; H NMR (DMSO-
d6): d 6.31–6.56 (bs, 2H, amide NH2), 7.10–7.40 (m, 5H, Ar-
H), 7.45 (d, J ¼ 8.4 Hz, 2H, Ar-H), 7.52 (d, J ¼ 8.4 Hz, 2H,
Ar-H), 11.25 (bs, 1H, NH); ms: m/z 381 (Mþ, 100%), 383
(Mþ2, 33%). Anal. Calcd. for C19H12ClN3O2S (381.03): C,
59.76; H, 3.17; N, 11.00. Found: C, 59.68; H, 3.28; N, 11.16.
5-(4-Chlorophenyl)-3,4-dihydro-2-(chloromethyl)-4-oxothieno-
[2,3-d]pyrimidine6-carboxamide (11c). This compound was
obtained as white amorphous solid, 0.246 g (70ꢀ%1), mp 267–
1640m, 1531m, 1323s cmꢀ1 1H NMR (DMSO-d6): d 6.60–
;
7.20 (bs, 2H, amide NH2), 6.65 (s, 1H, CH), 7.25 (d, J ¼
8.4 Hz, 2H, Ar-H), 7.32 (d, J ¼ 8.4 Hz, 2H, Ar-H), 7.82 (d,
J ¼ 8.9 Hz, 2H, Ar-H), 8.16 (d, J ¼ 8.9 Hz, 2H, Ar-H),
8.52 (bs, 1H, NH), 11.08 (bs, 1H, NH); ms: m/z 429 (Mþ,
100%), 431 (Mþ2, 33%). Anal. Calcd. for C19H13ClN4O4S
(429.04): C, 53.21; H, 3.06; N, 13.06. Found: C, 53.37; H,
3.24; N, 12.90.
269ꢂC; IR: 3489m, 3468m, 1665s, 1630m cm
;
1H NMR
(DMSO-d6): d 4.56 (s, 2H, CH2), 6.35–6.58 (bs, 2H, amide
NH2), 7.36 (d, J ¼ 8.3 Hz, 2H, Ar-H), 7.52 (d, J ¼ 8.3 Hz,
2H, Ar-H), 12.04 (bs, 1H, NH); 13C NMR (DMSO-d6): d
166.0, 164.9, 163.4, 143.2, 136.8, 133.7, 133.1, 131.6, 128.9,
125.6, 120.2, 42.4; ms: m/z 353 (Mþ, 100%), 355 (Mþ2,
65%), 357 (Mþ4, 11%). Anal. Calcd. for C14H9Cl2N3O2S
Acknowledgments. The authors gratefully acknowledge the
support for this research by UGC and CSIR New Delhi and Uni-
versity of Pune for spectroscopic analysis and Principal KTHM
College, Nashik-02 for facilities.
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet